tiprankstipranks
Trending News
More News >
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Income Statement

Compare
0 Followers

Jagsonpal Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), Jagsonpal Pharmaceuticals Ltd.'s total revenue was ₹585.60M, an increase of 34.66% from the same quarter last year. In Q4, Jagsonpal Pharmaceuticals Ltd.'s net income was ₹65.83M. See Jagsonpal Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 2.69B₹ 2.09B₹ 2.37B₹ 2.26B₹ 1.88B
Gross Profit
₹ 1.72B₹ 652.59M₹ 1.44B₹ 1.30B₹ 1.07B
Operating Expenses
₹ 709.33M₹ 438.55M₹ 1.11B₹ 1.05B₹ 881.55M
Depreciation and Amortization
₹ 81.31M₹ 16.63M₹ 11.75M₹ 15.26M₹ 10.86M
EBITDA
₹ 510.71M₹ 323.46M₹ 363.96M₹ 284.53M₹ 234.72M
Operating Income
₹ 1.01B₹ 214.04M₹ 338.85M₹ 239.87M₹ 187.86M
Other Income/Expenses
₹ -314.86M₹ 84.65M₹ 9.23M₹ 20.97M₹ 30.86M
Pretax Income
₹ 698.59M₹ 298.69M₹ 348.08M₹ 273.19M₹ 218.72M
Net Income
₹ 553.61M₹ 224.63M₹ 267.21M₹ 188.55M₹ 170.58M
Per Share Metrics
Basic EPS
₹ 8.26₹ 8.46₹ 10.20₹ 7.20₹ 6.51
Diluted EPS
₹ 8.22₹ 3.39₹ 10.20₹ 7.20₹ 6.51
Weighted Average Shares Outstanding
67.35M- 65.50M 65.50M 65.50M
Weighted Average Shares Outstanding (Diluted)
67.35M 66.30M 65.50M 65.50M 65.50M
Currency in INR

Jagsonpal Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis